Invasive fungal infections after obinutuzumab monotherapy for refractory chronic lymphocytic leukemia

被引:19
|
作者
Tse, Eric [1 ]
Leung, Rock Y. Y. [2 ]
Kwong, Yok-Lam [1 ]
机构
[1] Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[2] Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China
关键词
PHASE-II GAUGUIN; LYMPHOMA; GA101;
D O I
10.1007/s00277-014-2120-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:165 / 167
页数:3
相关论文
共 50 条
  • [1] Invasive fungal infections after obinutuzumab monotherapy for refractory chronic lymphocytic leukemia
    Eric Tse
    Rock Y. Y. Leung
    Yok-Lam Kwong
    [J]. Annals of Hematology, 2015, 94 : 165 - 167
  • [2] Obinutuzumab monotherapy in previously untreated chronic lymphocytic leukemia
    Gay, Nathan D.
    Kozin, Eliana
    Okada, Craig
    Danilov, Alexey V.
    Spurgeon, Stephen
    [J]. LEUKEMIA & LYMPHOMA, 2018, 59 (09) : 2258 - 2260
  • [3] High rates of proven invasive fungal disease with the use of ibrutinib monotherapy for relapsed or refractory chronic lymphocytic leukemia
    Teh, Benjamin W.
    Chui, William
    Handunnetti, Sasanka
    Tam, Constantine
    Worth, Leon J.
    Thursky, Karin A.
    Slavin, Monica A.
    [J]. LEUKEMIA & LYMPHOMA, 2019, 60 (06) : 1572 - 1575
  • [4] Fungal Infections in Chronic Lymphocytic Leukemia before and after Treatment
    Schoen, Martin W.
    Georgantopoulos, Peter
    Yalavarthi, Nagasai S.
    Bennett, Charles L.
    [J]. BLOOD, 2019, 134
  • [5] Obinutuzumab for chronic lymphocytic leukemia
    Rioufol, Catherine
    Salles, Gilles
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (05) : 533 - 543
  • [6] Obinutuzumab in chronic lymphocytic leukemia
    Dupuis, Jehan
    [J]. FUTURE ONCOLOGY, 2015, 11 (18) : 2503 - 2513
  • [7] Bendamustine monotherapy in advanced and refractory chronic lymphocytic leukemia
    Kath, R
    Blumenstengel, K
    Fricke, HJ
    Höffken, K
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2001, 127 (01) : 48 - 54
  • [8] Bendamustine monotherapy in advanced and refractory chronic lymphocytic leukemia
    R. Kath
    K. Blumenstengel
    H. J. Fricke
    K. Höffken
    [J]. Journal of Cancer Research and Clinical Oncology, 2001, 127 : 48 - 54
  • [9] OBINUTUZUMAB FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA
    Rogers, K. A.
    Jones, J. A.
    [J]. DRUGS OF TODAY, 2014, 50 (06) : 407 - 419
  • [10] Addition of rituximab in relapsed/refractory chronic lymphocytic leukemia after progression on venetoclax monotherapy
    Handunnetti, Sasanka
    Anderson, Mary Ann
    Roberts, Andrew W.
    Davids, Matthew S.
    Ma, Shuo
    Boyer, Michelle
    Arzt, Jennifer
    Al Masud, Abdullah
    Popovic, Relja
    Jacobson, Amanda
    Kim, Su Y.
    Seymour, John F.
    [J]. EJHAEM, 2021, 2 (02): : 266 - 271